Office Of Drug Evaluation Announces New Deputy Office Director
OPEN MINDS, The Behavioral Health & Social Service Industry Analyst
Industry Newsmakers
On May 30, 2003, the Food & Drug Administration (FDA) announced Brian Harvey, M.D. Ph.D., as the new deputy office director at Office of Drug Evaluation. Dr. Harvey joined FDA in 1995 as a medical officer and has served in clinical review and management positions in both the medical devices and biologic centers at FDA . . .